WallStreetZenWallStreetZen

NYSEMKT: XTNT
Xtant Medical Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XTNT

Based on 2 analysts offering 12 month price targets for Xtant Medical Holdings Inc

Min Forecast
$1.00+212.5%
Avg Forecast
$1.00+212.5%
Max Forecast
$1.00+212.5%

Should I buy or sell XTNT stock?

Based on 2 analysts offering ratings for Xtant Medical Holdings Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their XTNT stock forecasts and price targets.

XTNT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-02
lockedlocked$00.00+00.00%2026-05-13

1 of 1

Forecast return on equity

Is XTNT forecast to generate an efficient return?

Company
53.64%
Industry
22.47%
Market
168.71%
XTNT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XTNT forecast to generate an efficient return on assets?

Company
26.94%
Industry
13.73%
XTNT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XTNT earnings per share forecast

What is XTNT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.06
Avg 2 year Forecast
$0.01
Avg 3 year Forecast
-$0.01

XTNT revenue forecast

What is XTNT's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$101.5M-7.33%
Avg 2 year Forecast
$108.1M-1.28%
Avg 3 year Forecast
$112.6M+2.79%
XTNT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XTNT revenue growth forecast

How is XTNT forecast to perform vs Medical Devices companies and vs the US market?

Company
0.92%
Industry
7.26%
Market
13.78%
XTNT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XTNT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XTNT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
XTNT$0.32$1.00+212.50%Strong Buy
BDMD$1.05N/AN/A
SRTS$3.05$4.00+31.15%Strong Buy
SNWV$4.55N/AN/A
NNOX$0.73$4.33+490.33%Strong Buy
View Top Medical Device Stocks

Xtant Medical Holdings Stock Forecast FAQ

Is Xtant Medical Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: XTNT) stock is to Strong Buy XTNT stock.

Out of 2 analysts, 2 (100%) are recommending XTNT as a Strong Buy, 0 (0%) are recommending XTNT as a Buy, 0 (0%) are recommending XTNT as a Hold, 0 (0%) are recommending XTNT as a Sell, and 0 (0%) are recommending XTNT as a Strong Sell.

If you're new to stock investing, here's how to buy Xtant Medical Holdings stock.

What is XTNT's earnings growth forecast for 2026-2027?

(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.22%.

Xtant Medical Holdings's earnings in 2026 is -$11,137,000.On average, 4 Wall Street analysts forecast XTNT's earnings for 2026 to be -$8,585,623, with the lowest XTNT earnings forecast at -$10,998,576, and the highest XTNT earnings forecast at -$5,892,094. On average, 5 Wall Street analysts forecast XTNT's earnings for 2027 to be $1,430,937, with the lowest XTNT earnings forecast at -$2,749,644, and the highest XTNT earnings forecast at $5,892,094.

In 2027, XTNT is forecast to generate -$715,469 in earnings, with the lowest earnings forecast at -$4,124,466 and the highest earnings forecast at $2,946,047.

What is XTNT's revenue growth forecast for 2026-2027?

(NYSEMKT: XTNT) Xtant Medical Holdings's forecast annual revenue growth rate of 0.92% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.

Xtant Medical Holdings's revenue in 2026 is $109,527,000.On average, 5 Wall Street analysts forecast XTNT's revenue for 2026 to be $14,239,227,940, with the lowest XTNT revenue forecast at $13,473,255,678, and the highest XTNT revenue forecast at $14,808,797,058. On average, 5 Wall Street analysts forecast XTNT's revenue for 2027 to be $15,167,934,235, with the lowest XTNT revenue forecast at $14,298,148,883, and the highest XTNT revenue forecast at $16,041,928,226.

In 2027, XTNT is forecast to generate $15,793,618,537 in revenue, with the lowest revenue forecast at $15,068,329,784 and the highest revenue forecast at $16,350,561,738.

What is XTNT's forecast return on assets (ROA) for 2026-2029?

(NYSEMKT: XTNT) forecast ROA is 26.94%, which is higher than the forecast US Medical Devices industry average of 13.73%.

What is XTNT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year XTNT price target, the average XTNT price target is $1.00, with the highest XTNT stock price forecast at $1.00 and the lowest XTNT stock price forecast at $1.00.

On average, Wall Street analysts predict that Xtant Medical Holdings's share price could reach $1.00 by Sep 2, 2027. The average Xtant Medical Holdings stock price prediction forecasts a potential upside of 212.5% from the current XTNT share price of $0.32.

What is XTNT's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: XTNT) Xtant Medical Holdings's current Earnings Per Share (EPS) is -$0.08. On average, analysts forecast that XTNT's EPS will be -$0.06 for 2026, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at -$0.04. On average, analysts forecast that XTNT's EPS will be $0.01 for 2027, with the lowest EPS forecast at -$0.02, and the highest EPS forecast at $0.04. In 2027, XTNT's EPS is forecast to hit -$0.01 (min: -$0.03, max: $0.02).

What is XTNT's forecast return on equity (ROE) for 2026-2029?

(NYSEMKT: XTNT) forecast ROE is 53.64%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.